申请人:The Upjohn Company
公开号:US04012413A1
公开(公告)日:1977-03-15
Compounds of the formula: ##STR1## wherein R is hydrogen, methyl, or ethyl; wherein R' and R" are hydrogen, alkyl of 1 to 3 carbon atoms, inclusive, wherein R.sub.1 is hydrogen or methyl defined as above; wherein R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are selected from the group consisting of hydrogen, alkyl defined as above, halogen, nitro, trifluoromethyl, and alkoxy and alkylthio, in which the carbon chain moieties are of 1 to 3 carbon atoms, inclusive; and wherein the 5 to 6 nitrogen-carbon linkage is selected from the group consisting of double bonds and single bonds, are produced by a variety of multistep processes. The new compounds of formula X above and the pharmacologically acceptable acid addition salts thereof have oral and parenteral sedative and tranquilizing activity, and anti-depressant activity and can be employed for tranquilizing mammals as well as combating anxiety and depressions.
化合物的公式为:##STR1## 其中R为氢,甲基或乙基; R'和R"为氢,1至3个碳原子的烷基,其中R.sub.1为上述定义的氢或甲基; R.sub.2,R.sub.3,R.sub.4和R.sub.5从由氢,上述定义的烷基,卤素,硝基,三氟甲基和1至3个碳原子的碳链基团的烷氧基和烷硫基中选择; 其中5至6个氮-碳连接在双键和单键之间选择,通过多步反应制备。上述公式X的新化合物及其药理学上可接受的酸盐具有口服和静脉镇静和镇定作用,抗抑郁作用,并可用于镇静哺乳动物以及对抗焦虑和抑郁症。